Doubled chance of sustained remission in follicular lymphoma with rituximab maintenance

被引：0
|
作者：
Marcus, Robert [1 ]
机构：
[1] Kings Coll Hosp, London, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2010年 / 71卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [31] Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance
    Roy, Rupali
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 563 - 571
  • [32] Meta analysis: Rituximab as maintenance therapy for patients with follicular lymphoma
    Vidal, Liat
    Gafter-Gvili, Anat
    Dreyling, Martin
    Ghielmini, Michele
    Hsu-Schmitz, Shu Fang
    Leonard, Leibovici
    Cohen, Amos
    Shpilberg, Ofer
    BLOOD, 2007, 110 (11) : 998A - 998A
  • [33] RESULTS OF MAINTENANCE THERAPY WITH RITUXIMAB IN FOLLICULAR NON HODGKIN LYMPHOMA
    Soria, B.
    Olave, M. T.
    Rubio-Escuin, R.
    Rubio-Martinez, A.
    Palomera, L.
    Fuertes, M. A.
    Mayayo, P.
    Recasens, V.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 112 - 112
  • [34] Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
    Buchegger, Franz
    Press, Oliver W.
    EJNMMI RESEARCH, 2011, 1
  • [35] THE COST EFFECTIVENESS OF RITUXIMAB MAINTENANCE THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Mervin, M. C.
    VALUE IN HEALTH, 2016, 19 (03) : A153 - A153
  • [36] Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma
    Aguiar-Bujanda, David
    Jesus Blanco-Sanchez, Maria
    Hernandez-Sosa, Maria
    Galvan-Ruiz, Saray
    Hernandez-Sarmiento, Samuel
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 319 - 330
  • [37] Remission of transient acantholytic dermatosis after the treatment with rituximab for follicular lymphoma
    Ishibashi, M.
    Nagasaka, T.
    Chen, K. -R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (02) : 206 - 207
  • [38] Rituximab Maintenance Benefits Less for Follicular Lymphoma Patients with Low Risk of the Follicular Lymphoma International Index
    Wang, Tingyu
    Li, Ru
    Lv, Rui
    Yu, Ying
    Chen, Jiawen
    Xiong, Wenjie
    Wang, Qi
    Liu, Wei
    Huang, Wenyang
    Sui, Weiwei
    An, Gang
    Xu, Yan
    Zou, Dehui
    Wang, Jianxiang
    Qiu, Lugui
    Yi, Shuhua
    Wang, Yi
    BLOOD, 2021, 138
  • [39] Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
    Hill, Brian T.
    Nastoupil, Loretta
    Winter, Allison M.
    Becnel, Melody R.
    Cerhan, James R.
    Habermann, Thomas M.
    Link, Brian K.
    Maurer, Matthew J.
    Fakhri, Bita
    Reddy, Prathima
    Smith, Stephen D.
    Mukhija, Dhruvika
    Jagadeesh, Deepa
    Desai, Amrita
    Alderuccio, Juan Pablo
    Lossos, Izidore S.
    Mehra, Pooja
    Portell, Craig A.
    Goldman, Max L.
    Calzada, Oscar
    Cohen, Jonathon B.
    Hussain, Mohammad J.
    Ghosh, Nilanjan
    Caimi, Paolo
    Tiutan, Timothy
    Martin, Peter
    Kodali, Abhigna
    Evens, Andrew M.
    Kahl, Brad S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 524 - 535
  • [40] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
    Ritchie, David
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 402 - 403
12345